Literature DB >> 26164226

Adult outcomes after surgery for Hirschsprung's disease: Evaluation of bowel function and quality of life.

Anna Löf Granström1, Johan Danielson2, Britt Husberg3, Agneta Nordenskjöld4, Tomas Wester4.   

Abstract

BACKGROUND AND AIMS: Hirschsprung's disease (HSCR) is treated surgically. There is a risk for faecal incontinence and constipation postoperatively. The long-term bowel functional outcome in adults and quality of life are sparsely studied. The aim of this study was to assess bowel function and quality of life in patients who had undergone surgery for HSCR during childhood.
METHODS: All patients treated between 1969 and 1994 at St. Göran's Children's Hospital in Stockholm were invited to participate in the study. After consent, the patients received questionnaires containing general questions, validated questions on bowel function, questions about urinary function, SF-36 health survey (SF-36) and the Gastrointestinal Quality of Life Index (GIQLI). Clinical data were extracted from the case records. Controls matched for sex and age were randomly selected from the National Swedish Population Register.
RESULTS: 48 of 60 (80%) invited patients responded to the questionnaires. Nine patients were excluded since the HSCR diagnosis could not be confirmed. The median age of the included patients was 28 (20-43) years. Most patients had undergone Soave's operation (73.4%) and two patients had a stoma at the time of follow-up. The bowel function was impaired in the HSCR group compared to controls, especially problems with flatulence, need to strain at defecation and several defecations for emptying. Patients in the HSCR group also had significantly more problems with faecal incontinence than controls. Quality of life according to SF-36 did not differ significantly between patients and controls, but the GIQLI score showed a significantly worse outcome in the HSCR group compared to the controls.
CONCLUSION: General quality of life in adults treated for HSCR during childhood is comparable to controls. However, they have impaired bowel function and gastrointestinal quality of life.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bowel function; Gastrointestinal quality of life; Hirschsprung’s disease; Long-term follow-up; Quality of life

Mesh:

Year:  2015        PMID: 26164226     DOI: 10.1016/j.jpedsurg.2015.06.014

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  13 in total

1.  High Levels of Interest in Reproductive Genetic Information in Parents of Children and Adults With Hirschsprung Disease.

Authors:  Courtney D Berrios; Aravinda Chakravarti; Barbara B Biesecker
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-09       Impact factor: 2.839

2.  Premigratory neural crest stem cells generate enteric neurons populating the mouse colon and regulating peristalsis in tissue-engineered intestine.

Authors:  Huipu Yuan; Hui Hu; Rui Chen; Wenbo Mu; Liangliang Wang; Ying Li; Yuelei Chen; Xiaoyan Ding; Yongmei Xi; ShanShan Mao; Mizu Jiang; Jie Chen; Yong He; Lang Wang; Yi Dong; Jinfa Tou; Wei Chen
Journal:  Stem Cells Transl Med       Date:  2021-01-22       Impact factor: 6.940

3.  Reoperation in an adult female with "right-sided" Hirschsprung's disease complicated by refractory hypertension and cough.

Authors:  Zhi-Jian Wei; Lei Huang; A-Man Xu
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

Review 4.  ERNICA guidelines for the management of rectosigmoid Hirschsprung's disease.

Authors:  Kristiina Kyrklund; Cornelius E J Sloots; Ivo de Blaauw; Kristin Bjørnland; Udo Rolle; Duccio Cavalieri; Paola Francalanci; Fabio Fusaro; Annette Lemli; Nicole Schwarzer; Francesco Fascetti-Leon; Nikhil Thapar; Lars Søndergaard Johansen; Dominique Berrebi; Jean-Pierre Hugot; Célia Crétolle; Alice S Brooks; Robert M Hofstra; Tomas Wester; Mikko P Pakarinen
Journal:  Orphanet J Rare Dis       Date:  2020-06-25       Impact factor: 4.123

5.  Controlled outcome of Hirschsprung's disease beyond adolescence: a single center experience.

Authors:  Elisabet Gustafson; Therese Larsson; Johan Danielson
Journal:  Pediatr Surg Int       Date:  2018-11-20       Impact factor: 1.827

6.  Associations of SLC6A20 genetic polymorphisms with Hirschsprung's disease in a Southern Chinese population.

Authors:  Xiaoli Xie; Qiuming He; Lihua Huang; Le Li; Yuxiao Yao; Huimin Xia; Jinglu Zhao; Wei Zhong; Yan Zhang
Journal:  Biosci Rep       Date:  2019-08-13       Impact factor: 3.840

7.  Long-term outcomes and quality of life of patients with Hirschsprung disease: a systematic review and meta-analysis.

Authors:  Ying Dai; Yongfang Deng; Yan Lin; Runxian Ouyang; Le Li
Journal:  BMC Gastroenterol       Date:  2020-03-12       Impact factor: 3.067

8.  Pan-enteric neuropathy and dysmotility are present in a mouse model of short-segment Hirschsprung disease and may contribute to post-pullthrough morbidity.

Authors:  Sukhada Bhave; Emily Arciero; Corey Baker; Wing Lam Ho; Richard A Guyer; Ryo Hotta; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2020-04-17       Impact factor: 2.545

9.  Optimal timing for Soave primary pull-through in short-segment Hirschsprung disease: A meta-analysis.

Authors:  Maggie L Westfal; Ongoly Okiemy; Patrick Ho Yu Chung; Jiexiong Feng; Changgui Lu; Go Miyano; Paul Kwong Hang Tam; Weibing Tang; Kenneth Kak Yuen Wong; Atsuyuki Yamataka; Richard A Guyer; Daniel P Doody; Allan M Goldstein
Journal:  J Pediatr Surg       Date:  2021-07-21       Impact factor: 2.545

10.  Diagnosis and surgical approach of adult Hirschsprung's disease: About two observations and review of the literature. Case series.

Authors:  Harissou Adamou; Ibrahim Amadou Magagi; Oumarou Habou; Ousseini Adakal; Maman Bachir Aboulaye; Alliance Robnodji; Lassey James Didier; Rachid Sani; Habibou Abarchi
Journal:  Ann Med Surg (Lond)       Date:  2019-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.